Today: 17 April 2026
Nebius Stock (NBIS) Jumps as BofA Backs AI Trade, but Downgrade Flags Valuation Risk
13 April 2026
2 mins read

Nebius Stock (NBIS) Jumps as BofA Backs AI Trade, but Downgrade Flags Valuation Risk

NEW YORK, April 13, 2026, 12:06 EDT

Nebius Group jumped 7.4% Monday, trading at $155.74 by 11:51 a.m. EDT, as demand for AI infrastructure plays stayed hot—despite Freedom Capital Markets dropping its rating to Hold. Earlier, Bank of America lifted its price target for Nebius to $175 from $150, sticking with a Buy.

The surge is significant: Nebius has become something of a bellwether for AI computing budgets as investors start hunting beyond the usual cloud giants for the next breakout. Based in Amsterdam, the company ranks among the bigger neocloud outfits—those niche operators leasing AI chips and cloud infrastructure to other tech firms. Reuters reported Nebius has ridden the same AI spending wave that’s lifted CoreWeave, its bigger competitor, as enterprise appetite for AI remains undeterred.

Analysts took opposing stances on Monday. BofA’s Tal Liani, as cited by The Fly via TipRanks, pointed to fresh contracts at Nebius and CoreWeave as evidence that AI infrastructure demand remains strong, calling Nebius a key supplier. On the other hand, Paul Meeks of Freedom Capital downgraded Nebius to Hold from Buy, even as he hiked his price target to $154 from $108. After a roughly 70% gain since early February, he sees the stock as “overbought” and prefers CoreWeave and Applied Digital for better short-term risk-reward. TipRanks

Nebius shares jumped 21.1% between last Friday’s close and Thursday, according to The Motley Fool. Fueling the rally: Cantor Fitzgerald’s new Overweight rating and a report from The Information—picked up later by Reuters—about Nebius holding takeover talks with Israeli AI firm AI21 Labs. Back in February, Reuters noted CEO Arkady Volozh told shareholders demand was still running ahead of supply, with Nebius aiming to grow “both organically and through targeted acquisitions.” The Motley Fool

For now, bulls are leaning hard on sheer scale and contract wins. On March 16, Nebius announced a five-year AI infrastructure deal with Meta, potentially totaling $27 billion—$12 billion locked in for dedicated capacity from early 2027, with up to $15 billion more possible over the full term. “We will continue to deliver,” Volozh said. Nebius

Nebius has locked in supply deals topping $40 billion with Microsoft and Meta, Reuters reported March 31. Its upcoming 310-megawatt facility in Lappeenranta, Finland is set to rank among Europe’s biggest, with phased openings starting in 2027. “Significant contribution” is how Volozh described what the new site will mean for the firm’s capacity plans. Reuters

The expansion hasn’t lacked for capital. Last month, Reuters said Nebius wrapped up $4.34 billion in convertible debt—bonds that can be turned into stock down the line—after a $2 billion warrant sale to Nvidia. “Well-funded” is how Chief Communications Officer Tom Blackwell put it, noting the company is set for 2026 capital expenditures between $16 billion and $20 billion. He also pointed to long-term contracts as a cost-effective funding route, provided they’re structured properly. Reuters

Still, the risks stand out. According to a Reuters piece from February, Nebius ramped up capital spending to roughly $2.1 billion in the December quarter, with net losses deepening to $249.6 million—even revenue soared more than six times. Any slowdown in demand, tighter financing, or a misstep on a major acquisition could leave the stock exposed after its recent surge.

Investors continue to shell out for capacity, contracts, and speed, for now. But by late morning Monday, shares had already climbed past Meeks’s freshly set $154 target—a signal that even among red-hot AI stocks, valuation’s back in focus.

Stock Market Today

  • Indian Stock Market Ends Flat; Gift Nifty Signals Cautious Start Amid US-Iran Ceasefire Hopes
    April 17, 2026, 12:05 AM EDT. The Indian stock market ended Thursday in a volatile but flat session, with the Nifty 50 closing down 34 points at 24,196 and Sensex down 122 points to 77,988. The Bank Nifty fell 215 points to 56,086. Sector performance was mixed-metals, IT, and energy supported the market while banking and auto stocks declined. Broader markets outperformed, with midcap and smallcap indices up 0.6-1%. Gift Nifty futures traded flat near 24,175, indicating a muted opening for Friday. Globally, Wall Street rallied on optimism over a potential US-Iran ceasefire, pushing the S&P 500 and Nasdaq to record highs. Asian markets stayed cautious, reflecting regional geopolitical uncertainties. Gold and silver prices gained on renewed ceasefire hope amid easing crude prices, with gold near $4,800/oz and silver at $78.50/oz on COMEX. Market-watchers expect cautious trading ahead amid mixed cues.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 17.04.2026

17 April 2026
LIVEMarkets rolling coverageStarted: April 17, 2026, 12:00 AM EDTUpdated: April 17, 2026, 12:09 AM EDT Indian Stock Market Ends Flat; Gift Nifty Signals Cautious Start Amid US-Iran Ceasefire Hopes April 17, 2026, 12:05 AM EDT. The Indian stock market ended Thursday in a volatile but flat session, with the Nifty 50 closing down 34 points at 24,196 and Sensex down 122 points to 77,988. The Bank Nifty fell 215 points to 56,086. Sector performance was mixed-metals, IT, and energy supported the market while banking and auto stocks declined. Broader markets outperformed, with midcap and smallcap indices up 0.6-1%. Gift Nifty
Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

16 April 2026
Hims & Hers Health shares rose to $26.65 Thursday after the FDA said it would reconsider restrictions on several peptides, removing 12 from a high-risk list and scheduling a July review of seven more. The move follows Hims’ March decision to stop advertising compounded GLP-1 drugs and expand branded offerings through Novo Nordisk. The company acquired a California peptide facility last year to bolster supply.
NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

16 April 2026
NuScale Power shares jumped to $13.23 before falling back to $11.52 Thursday after the White House ordered NASA to start a space-reactor program and Energy Secretary Chris Wright said initial U.S. reactors would likely get federal loans. NuScale remains the only U.S. firm with an approved small modular reactor design but has yet to secure firm orders or financing.
SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

16 April 2026
SoFi Technologies shares rose 1.5% Thursday after launching instant bank transfers via its Galileo platform, allowing money to move between SoFi and outside banks in seconds. The stock traded near $19.08 in New York. Investors await first-quarter results April 29, with SoFi guiding to $1.04 billion in adjusted net revenue and 12 cents per share in adjusted earnings.
D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

16 April 2026
D-Wave Quantum shares climbed about 5% Thursday, extending a 22.6% surge after Nvidia launched Ising, a new AI model family for quantum computing. D-Wave traded at $21.81, up from last year’s lows, and reported 2025 revenue of $24.6 million with first-quarter 2026 bookings topping $32.8 million. The company completed its $250 million Quantum Circuits acquisition in January. Market cap stood near $8.4 billion.
IBM Stock Gets Citi Buy Call Despite Worst Start Since 2002 as BofA Cuts Target Ahead of Earnings
Previous Story

IBM Stock Gets Citi Buy Call Despite Worst Start Since 2002 as BofA Cuts Target Ahead of Earnings

Intel Stock Rally Extends as $100 Billion April Run Draws Fresh Wall Street Bets
Next Story

Intel Stock Rally Extends as $100 Billion April Run Draws Fresh Wall Street Bets

Go toTop